Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/BCTX/Capital expenditures

BRIACELL THERAPEUTICS CORP. (BCTX) Capital expenditures 2024–2026

BRIACELL THERAPEUTICS CORP. (BCTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$127,049FY2026 · since FY2024: $456,801 → $127,049
2426
Fiscal yearValueYoY
FY2026$127,049—
FY2024$456,801—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More BCTX financial trends

BCTX RevenueBCTX Net incomeBCTX Net marginBCTX Gross profitBCTX Gross marginBCTX Operating incomeBCTX Operating marginBCTX Operating cash flowBCTX Free cash flowBCTX Return on equityBCTX Stock buybacksBCTX Dividends paidBCTX Total assetsBCTX Total liabilitiesBCTX Shareholders’ equityBCTX overview →